BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 31492632)

  • 1. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
    Farge D; Frere C; Connors JM; Ay C; Khorana AA; Munoz A; Brenner B; Kakkar A; Rafii H; Solymoss S; Brilhante D; Monreal M; Bounameaux H; Pabinger I; Douketis J;
    Lancet Oncol; 2019 Oct; 20(10):e566-e581. PubMed ID: 31492632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of deep vein thrombosis in cancer patients.
    Lee AY
    Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trousseau's syndrome: cancer-associated thrombosis.
    Ikushima S; Ono R; Fukuda K; Sakayori M; Awano N; Kondo K
    Jpn J Clin Oncol; 2016 Mar; 46(3):204-8. PubMed ID: 26546690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer.
    Farge D; Bounameaux H; Brenner B; Cajfinger F; Debourdeau P; Khorana AA; Pabinger I; Solymoss S; Douketis J; Kakkar A
    Lancet Oncol; 2016 Oct; 17(10):e452-e466. PubMed ID: 27733271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
    Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: A systematic review and network meta-analysis.
    Rossel A; Robert-Ebadi H; Combescure C; Grosgurin O; Stirnemann J; Addeo A; Garin N; Agoritsas T; Reny JL; Marti C
    PLoS One; 2019; 14(3):e0213940. PubMed ID: 30897142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of direct oral anticoagulants for the treatment of cancer-associated thrombosis: an update.
    Franco-Moreno A; Cabezón-Gutiérrez L; Palka-Kotlowsa M; Villamayor-Delgado M; García-Navarro M
    J Thromb Thrombolysis; 2019 Apr; 47(3):409-419. PubMed ID: 30467760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation for COVID-19 Patients: A Bird's-Eye View.
    Kreidieh F; Temraz S
    Clin Appl Thromb Hemost; 2021; 27():10760296211039288. PubMed ID: 34595937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulant use in cancer patients.
    Trujillo-Santos J; Monreal M
    Expert Opin Pharmacother; 2011 Feb; 12(3):351-62. PubMed ID: 21254944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from French National Guidelines on the treatment of venous thrombosis and central venous catheter thrombosis in cancer patients.
    Farge D; Durant C; Villiers S; Long A; Mahr A; Marty M; Debourdeau P;
    Thromb Res; 2010 Apr; 125 Suppl 2():S108-16. PubMed ID: 20433988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19.
    Farge D; Frere C; Connors JM; Khorana AA; Kakkar A; Ay C; Muñoz A; Brenner B; Prata PH; Brilhante D; Antic D; Casais P; Guillermo Esposito MC; Ikezoe T; Abutalib SA; Meillon-García LA; Bounameaux H; Pabinger I; Douketis J;
    Lancet Oncol; 2022 Jul; 23(7):e334-e347. PubMed ID: 35772465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editor's Choice - A Systematic Review and Meta-Analysis of the Efficacy and Safety of Anticoagulation in the Treatment of Venous Thromboembolism in Patients with Cancer.
    Kirkilesis GI; Kakkos SK; Tsolakis IA
    Eur J Vasc Endovasc Surg; 2019 May; 57(5):685-701. PubMed ID: 31097186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A consensus viewpoint on the role of direct factor Xa inhibitors in the management of cancer-associated venous thromboembolism in the UK.
    Cohen AT; Benson G; Bradbury CA; Choudhuri S; Hutchinson Jones N; Maraveyas A; Venugopal B; Young AM; Chapman C; McIntyre S; Burney D; Pollock KG; Morgan AR; Gabb PD; Alikhan R
    Curr Med Res Opin; 2023 Mar; 39(3):483-495. PubMed ID: 36629478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
    Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New international guidelines for curative treatment and prophylaxis for venous thromboembolism (VTE) in cancer patients and the dedicated smartphone application].
    Benzidia I; Connault J; Solanilla A; Michon-Pasturel U; Jamelot M; Nguessan MK; Hij A; Le Maignan C; Farge D; Frère C;
    J Med Vasc; 2017 Dec; 42(6):375-383. PubMed ID: 29203044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thoughts about thromboembolic events prophylaxis in cancer patients].
    Pikó B; Kremer IM; Rahoty P; Bassam A; Dimák S; Kis A; Csiffári M; Rus-Gal P; Szabó Z; Veréb B; Zsilak J
    Magy Onkol; 2011 Sep; 55(3):164-9. PubMed ID: 21918741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis against venous thromboembolism in orthopedic surgery.
    Liu LT; Ma BT
    Chin J Traumatol; 2006 Aug; 9(4):249-56. PubMed ID: 16849000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of venous thromboembolism in cancer patients.
    Petralia GA; Kakkar AK
    Semin Thromb Hemost; 2007 Oct; 33(7):707-11. PubMed ID: 18000799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-center, retrospective evaluation of safety and efficacy of direct oral anticoagulants versus low-molecular-weight heparin and vitamin K antagonist in patients with cancer.
    Pritchard ER; Murillo JR; Putney D; Hobaugh EC
    J Oncol Pharm Pract; 2019 Jan; 25(1):52-59. PubMed ID: 28825375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.